NCT01480648View on ClinicalTrials.gov

Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 29, 2012

Conditions
Healthy
Interventions
DRUG

BI 144807 Placebo

Placebo that represents BI drug

DRUG

BI 144807

single dose (low to high dose)

Trial Locations (1)

Unknown

1313.1.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY